Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Chattem, Inc. (Chattem or "the company") is a manufacturer and marketer of branded over-the-counter (OTC) healthcare products, toiletries and dietary supplements. The company primarily operates in the US. It is headquartered in Chattanooga, Tennessee and employs about 524 people.
Published By MarketLine
|
05 Aug 2010 |
$175
|
Company Profile
|
Cephalon is an international biopharmaceutical company engaged in discovering, developing and marketing drugs in three therapeutic areas: central nervous system (CNS), pain and oncology. The company primarily operates in the US and Europe. It is headquartered in Frazer, Pennsylvania and employed 3,726 people as of December 31, 2010.
Published By MarketLine
|
29 Aug 2011 |
$175
|
Company Profile
|
Celgene Corporation (Celgene or 'the company'), an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. The company is headquartered in Summit, New Jersey, and employed 4,460 people as of December 31, 2011.
Published By MarketLine
|
28 Dec 2012 |
$175
|
Industry Profile
|
Essential resource for top-line data and analysis covering the Canada OTC pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Published By MarketLine
|
20 Feb 2012 |
$350
|
Industry Profile
|
Essential resource for top-line data and analysis covering the Canada generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Published By MarketLine
|
04 Jul 2012 |
$350
|
Industry Profile
|
Essential resource for top-line data and analysis covering the Canada biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Published By MarketLine
|
19 Jul 2012 |
$350
|
Company Profile
|
Bristol-Myers Squibb Company (BMS or 'the company') is a global biopharmaceutical company. BMS was formed by the merger of Bristol Myers and Squibb Pharmaceuticals in 1989, a move which at the time created the world's second largest drug company. The company has its operations in the Americas, Europe, Japan, Asia, Australia, Middle East and Africa. BMS is headquartered in New York City, New York, and employed about 27,000 people as of December 31, 2011.
Published By MarketLine
|
30 Oct 2012 |
$175
|
Company Profile
|
BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in Novato, California, and employed 1,002 people as of January 27, 2012.
Published By MarketLine
|
06 Dec 2012 |
$175
|
Company Profile
|
Biogen Idec, Inc. (Biogen or 'the company') is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of oncology, neurology and immunology. The company's key products include Tysabri (natalizumab), Avonex (Interferon beta-1a), and Rituxan (rituximab). The company primarily operates in the US and Europe. It is headquartered in Weston, Massachusetts and employed about 5,000 people as of December 31, 2011.
Published By MarketLine
|
23 Nov 2012 |
$175
|
Company Profile
|
Auxilium Pharmaceuticals (Auxilium or 'the company') is a specialty biopharmaceutical company engaged in the development and marketing of pharmaceutical products that focus on urology and sexual health. It currently markets Testim for the treatment of hypogonadism; and Xiaflex for Dupuytren's contracture patients with a palpable cord. The company operates primarily in the US where it is headquartered in Malvern, Pennsylvania. It employed 530 people as of December 31, 2011.
Published By MarketLine
|
06 Jun 2012 |
$175
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.